U.S. Army Reinforces Cannabinoid Ban
The U.S. Army has reaffirmed its stringent military CBD policy, maintaining a zero-tolerance approach to all cannabis and cannabinoid-containing products for its service members. This directive, detailed in a recent blog post by the Army’s Directorate of Prevention, Resilience and Readiness, underscores that even hemp-derived CBD products, including lotions and gummies, are prohibited due to potential risks to soldiers and mission readiness.
Despite broader federal discussions, such as the Trump administration’s finalization of a medical marijuana rescheduling rule and efforts to maintain the legal status of full-spectrum CBD, the Army’s internal policy remains unchanged. Army Regulation 600-85, which governs the Army Substance Abuse Program, explicitly bans all forms of cannabis—including marijuana, hemp, and all cannabinoid-containing products—regardless of their marketing or consumption method. This policy applies uniformly, irrespective of state-level legality for marijuana or hemp.
Rationale for the Zero-Tolerance Approach
Army officials state that the Department of Defense’s policy is designed to maintain a healthy Army community and drug-free workplaces. Col. Kevin Goke, deputy director at the Army Directorate of Prevention, Resilience and Readiness, emphasized that this approach ensures soldiers can perform their duties while upholding the standards required for national defense. Andrea Donoghue, program manager for the Army Substance Abuse Program, acknowledged the complexity surrounding hemp, marijuana, and CBD, but reiterated the military branch’s comprehensive ban.
- Broad Scope: The ban encompasses everything from hemp-derived CBD to natural delta-9 THC in marijuana and synthetic cannabinoids.
- Product Diversity: Prohibited items include vape juices, food, hair care products, oils, lotions, cosmetics, and transdermal patches.
- Unreliable Labeling: Officials caution that products labeled as “THC-free” may be inaccurately labeled or lack consistent quality control, posing a risk of positive drug tests.
- Mission Readiness: The Army’s primary concern is that all types of cannabinoids can pose risks to both physical and mental readiness.
Col. Goke highlighted the significant risk posed by the unregulated consumer market, where THC contamination in commercial products is a documented and persistent problem. He added that until these products are regulated with the same rigor as pharmaceuticals, Army policy AR 600-85’s zero-tolerance stance remains absolute to protect soldiers’ careers and ensure mission readiness.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
